The current valuation score of Puma Biotechnology Inc is 5.76, ranking 143 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 16.24, which is 741908.78% below the recent high of 120500.00 and 511.66% above the recent low of -66.85.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.